These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7527670)

  • 1. Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: in vivo interactions and dose-response surfaces.
    de Haan G; Engel C; Dontje B; Nijhof W; Loeffler M
    Blood; 1994 Dec; 84(12):4157-63. PubMed ID: 7527670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo.
    Ulich TR; del Castillo J; McNiece IK; Yi ES; Alzona CP; Yin SM; Zsebo KM
    Blood; 1991 Oct; 78(8):1954-62. PubMed ID: 1717076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis.
    de Haan G; Dontje B; Engel C; Loeffler M; Nijhof W
    Br J Haematol; 1995 Aug; 90(4):783-90. PubMed ID: 7545423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of erythropoietin, granulocyte colony-stimulating factor, stem cell factor, and interleukin-11 on murine hematopoiesis during simultaneous administration.
    Roeder I; de Haan G; Engel C; Nijhof W; Dontje B; Loeffler M
    Blood; 1998 May; 91(9):3222-9. PubMed ID: 9558377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells.
    Rusten LS; Dybedal I; Blomhoff HK; Blomhoff R; Smeland EB; Jacobsen SE
    Blood; 1996 Mar; 87(5):1728-36. PubMed ID: 8634418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.
    Broxmeyer HE; Cooper S; Lu L; Hangoc G; Anderson D; Cosman D; Lyman SD; Williams DE
    Blood; 1991 May; 77(10):2142-9. PubMed ID: 1709371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis.
    Chen TL; Chiang YW; Lin GL; Chang HH; Lien TS; Sheh MH; Sun DS
    Stem Cell Res Ther; 2018 May; 9(1):119. PubMed ID: 29720275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
    de Haan G; Loeffler M; Nijhof W
    Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.
    Bernstein ID; Andrews RG; Zsebo KM
    Blood; 1991 Jun; 77(11):2316-21. PubMed ID: 1710148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor.
    Migliaccio G; Migliaccio AR; Druzin ML; Giardina PJ; Zsebo KM; Adamson JW
    Blood; 1992 May; 79(10):2620-7. PubMed ID: 1375106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy.
    de Haan G; Engel C; Dontje B; Loeffler M; Nijhof W
    Cancer Res; 1995 Jan; 55(2):324-9. PubMed ID: 7529132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment.
    Schirm S; Engel C; Loeffler M; Scholz M
    Theor Biol Med Model; 2014 May; 11():24. PubMed ID: 24886056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.
    McNiece IK; Langley KE; Zsebo KM
    Exp Hematol; 1991 Mar; 19(3):226-31. PubMed ID: 1704845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin.
    Johnson CS; Keckler DJ; Topper MI; Braunschweiger PG; Furmanski P
    Blood; 1989 Feb; 73(3):678-83. PubMed ID: 2783864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture system.
    Ward CS; Westwood NB; Emmerson AJ; Pearson TC
    Br J Haematol; 1992 Jul; 81(3):325-30. PubMed ID: 1382542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo.
    Hintz-Obertreis P; Weinmann E; Seiler FR
    Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.